nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranylcypromine—CYP2D6—Vinorelbine—ovarian cancer	0.0823	0.213	CbGbCtD
Tranylcypromine—CYP3A4—Topotecan—ovarian cancer	0.0743	0.192	CbGbCtD
Tranylcypromine—CYP2C9—Paclitaxel—ovarian cancer	0.0632	0.164	CbGbCtD
Tranylcypromine—CYP3A4—Vinorelbine—ovarian cancer	0.0523	0.135	CbGbCtD
Tranylcypromine—CYP3A4—Paclitaxel—ovarian cancer	0.0368	0.0951	CbGbCtD
Tranylcypromine—CYP2D6—Doxorubicin—ovarian cancer	0.0312	0.0806	CbGbCtD
Tranylcypromine—CYP3A4—Docetaxel—ovarian cancer	0.0266	0.0688	CbGbCtD
Tranylcypromine—CYP3A4—Doxorubicin—ovarian cancer	0.0198	0.0513	CbGbCtD
Tranylcypromine—MAOB—myometrium—ovarian cancer	0.00217	0.0594	CbGeAlD
Tranylcypromine—MAOB—embryo—ovarian cancer	0.00209	0.0571	CbGeAlD
Tranylcypromine—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.00193	0.00381	CcSEcCtD
Tranylcypromine—Hypotension—Melphalan—ovarian cancer	0.00192	0.00379	CcSEcCtD
Tranylcypromine—Hypertension—Vinorelbine—ovarian cancer	0.0019	0.00375	CcSEcCtD
Tranylcypromine—Paraesthesia—Topotecan—ovarian cancer	0.00188	0.00372	CcSEcCtD
Tranylcypromine—Urticaria—Chlorambucil—ovarian cancer	0.00187	0.0037	CcSEcCtD
Tranylcypromine—Abdominal pain—Chlorambucil—ovarian cancer	0.00186	0.00368	CcSEcCtD
Tranylcypromine—Body temperature increased—Chlorambucil—ovarian cancer	0.00186	0.00368	CcSEcCtD
Tranylcypromine—MAOA—myometrium—ovarian cancer	0.00185	0.0506	CbGeAlD
Tranylcypromine—Paraesthesia—Melphalan—ovarian cancer	0.00184	0.00365	CcSEcCtD
Tranylcypromine—Decreased appetite—Topotecan—ovarian cancer	0.00182	0.0036	CcSEcCtD
Tranylcypromine—Pain—Topotecan—ovarian cancer	0.00179	0.00355	CcSEcCtD
Tranylcypromine—Constipation—Topotecan—ovarian cancer	0.00179	0.00355	CcSEcCtD
Tranylcypromine—Decreased appetite—Melphalan—ovarian cancer	0.00179	0.00353	CcSEcCtD
Tranylcypromine—MAOA—embryo—ovarian cancer	0.00178	0.0487	CbGeAlD
Tranylcypromine—Thrombocytopenia—Vinorelbine—ovarian cancer	0.00176	0.00347	CcSEcCtD
Tranylcypromine—Pain—Melphalan—ovarian cancer	0.00176	0.00347	CcSEcCtD
Tranylcypromine—Tachycardia—Vinorelbine—ovarian cancer	0.00175	0.00346	CcSEcCtD
Tranylcypromine—Bradycardia—Paclitaxel—ovarian cancer	0.00173	0.00342	CcSEcCtD
Tranylcypromine—Feeling abnormal—Topotecan—ovarian cancer	0.00173	0.00342	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Topotecan—ovarian cancer	0.00172	0.00339	CcSEcCtD
Tranylcypromine—Anorexia—Vinorelbine—ovarian cancer	0.00171	0.00338	CcSEcCtD
Tranylcypromine—Haemoglobin—Paclitaxel—ovarian cancer	0.00171	0.00338	CcSEcCtD
Tranylcypromine—Haemorrhage—Paclitaxel—ovarian cancer	0.0017	0.00336	CcSEcCtD
Tranylcypromine—Asthenia—Chlorambucil—ovarian cancer	0.00169	0.00334	CcSEcCtD
Tranylcypromine—MAOB—uterine cervix—ovarian cancer	0.00169	0.0462	CbGeAlD
Tranylcypromine—Hypoaesthesia—Paclitaxel—ovarian cancer	0.00169	0.00334	CcSEcCtD
Tranylcypromine—Hypotension—Vinorelbine—ovarian cancer	0.00168	0.00331	CcSEcCtD
Tranylcypromine—Urticaria—Topotecan—ovarian cancer	0.00167	0.00329	CcSEcCtD
Tranylcypromine—Abdominal pain—Topotecan—ovarian cancer	0.00166	0.00328	CcSEcCtD
Tranylcypromine—Body temperature increased—Topotecan—ovarian cancer	0.00166	0.00328	CcSEcCtD
Tranylcypromine—Urticaria—Melphalan—ovarian cancer	0.00163	0.00323	CcSEcCtD
Tranylcypromine—Diarrhoea—Chlorambucil—ovarian cancer	0.00161	0.00319	CcSEcCtD
Tranylcypromine—Paraesthesia—Vinorelbine—ovarian cancer	0.00161	0.00319	CcSEcCtD
Tranylcypromine—MAOB—decidua—ovarian cancer	0.00161	0.044	CbGeAlD
Tranylcypromine—Tinnitus—Paclitaxel—ovarian cancer	0.00158	0.00313	CcSEcCtD
Tranylcypromine—Flushing—Paclitaxel—ovarian cancer	0.00158	0.00312	CcSEcCtD
Tranylcypromine—Decreased appetite—Vinorelbine—ovarian cancer	0.00156	0.00308	CcSEcCtD
Tranylcypromine—CYP2A6—vagina—ovarian cancer	0.00155	0.0424	CbGeAlD
Tranylcypromine—Constipation—Vinorelbine—ovarian cancer	0.00154	0.00303	CcSEcCtD
Tranylcypromine—Pain—Vinorelbine—ovarian cancer	0.00154	0.00303	CcSEcCtD
Tranylcypromine—MAOB—endometrium—ovarian cancer	0.00153	0.0418	CbGeAlD
Tranylcypromine—Chills—Paclitaxel—ovarian cancer	0.00152	0.00301	CcSEcCtD
Tranylcypromine—Asthenia—Topotecan—ovarian cancer	0.00151	0.00298	CcSEcCtD
Tranylcypromine—Alopecia—Paclitaxel—ovarian cancer	0.0015	0.00297	CcSEcCtD
Tranylcypromine—Vomiting—Chlorambucil—ovarian cancer	0.0015	0.00296	CcSEcCtD
Tranylcypromine—Agranulocytosis—Docetaxel—ovarian cancer	0.0015	0.00296	CcSEcCtD
Tranylcypromine—Feeling abnormal—Vinorelbine—ovarian cancer	0.00148	0.00292	CcSEcCtD
Tranylcypromine—Asthenia—Melphalan—ovarian cancer	0.00147	0.00291	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00147	0.0029	CcSEcCtD
Tranylcypromine—Haemoglobin—Docetaxel—ovarian cancer	0.00145	0.00286	CcSEcCtD
Tranylcypromine—MAOA—uterine cervix—ovarian cancer	0.00144	0.0394	CbGeAlD
Tranylcypromine—Hepatitis—Docetaxel—ovarian cancer	0.00144	0.00285	CcSEcCtD
Tranylcypromine—Haemorrhage—Docetaxel—ovarian cancer	0.00144	0.00285	CcSEcCtD
Tranylcypromine—Diarrhoea—Topotecan—ovarian cancer	0.00144	0.00284	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Docetaxel—ovarian cancer	0.00143	0.00283	CcSEcCtD
Tranylcypromine—Urticaria—Vinorelbine—ovarian cancer	0.00143	0.00282	CcSEcCtD
Tranylcypromine—Muscle spasms—Paclitaxel—ovarian cancer	0.00142	0.00281	CcSEcCtD
Tranylcypromine—Body temperature increased—Vinorelbine—ovarian cancer	0.00142	0.0028	CcSEcCtD
Tranylcypromine—Abdominal pain—Vinorelbine—ovarian cancer	0.00142	0.0028	CcSEcCtD
Tranylcypromine—MAOB—uterus—ovarian cancer	0.00141	0.0385	CbGeAlD
Tranylcypromine—Diarrhoea—Melphalan—ovarian cancer	0.00141	0.00278	CcSEcCtD
Tranylcypromine—Nausea—Chlorambucil—ovarian cancer	0.0014	0.00277	CcSEcCtD
Tranylcypromine—Vision blurred—Paclitaxel—ovarian cancer	0.00139	0.00276	CcSEcCtD
Tranylcypromine—Dizziness—Topotecan—ovarian cancer	0.00139	0.00274	CcSEcCtD
Tranylcypromine—Tremor—Paclitaxel—ovarian cancer	0.00139	0.00274	CcSEcCtD
Tranylcypromine—MAOA—decidua—ovarian cancer	0.00137	0.0375	CbGeAlD
Tranylcypromine—Anaemia—Paclitaxel—ovarian cancer	0.00137	0.0027	CcSEcCtD
Tranylcypromine—Agitation—Paclitaxel—ovarian cancer	0.00136	0.00269	CcSEcCtD
Tranylcypromine—Flushing—Docetaxel—ovarian cancer	0.00134	0.00264	CcSEcCtD
Tranylcypromine—Vomiting—Topotecan—ovarian cancer	0.00133	0.00264	CcSEcCtD
Tranylcypromine—Syncope—Paclitaxel—ovarian cancer	0.00133	0.00262	CcSEcCtD
Tranylcypromine—Leukopenia—Paclitaxel—ovarian cancer	0.00132	0.00262	CcSEcCtD
Tranylcypromine—Rash—Topotecan—ovarian cancer	0.00132	0.00261	CcSEcCtD
Tranylcypromine—Dermatitis—Topotecan—ovarian cancer	0.00132	0.00261	CcSEcCtD
Tranylcypromine—Ataxia—Epirubicin—ovarian cancer	0.00132	0.00261	CcSEcCtD
Tranylcypromine—Headache—Topotecan—ovarian cancer	0.00131	0.0026	CcSEcCtD
Tranylcypromine—Palpitations—Paclitaxel—ovarian cancer	0.00131	0.00258	CcSEcCtD
Tranylcypromine—Vomiting—Melphalan—ovarian cancer	0.00131	0.00258	CcSEcCtD
Tranylcypromine—MAOA—endometrium—ovarian cancer	0.0013	0.0356	CbGeAlD
Tranylcypromine—Loss of consciousness—Paclitaxel—ovarian cancer	0.0013	0.00257	CcSEcCtD
Tranylcypromine—Rash—Melphalan—ovarian cancer	0.0013	0.00256	CcSEcCtD
Tranylcypromine—Dermatitis—Melphalan—ovarian cancer	0.00129	0.00256	CcSEcCtD
Tranylcypromine—Chills—Docetaxel—ovarian cancer	0.00129	0.00255	CcSEcCtD
Tranylcypromine—Asthenia—Vinorelbine—ovarian cancer	0.00129	0.00255	CcSEcCtD
Tranylcypromine—Hypertension—Paclitaxel—ovarian cancer	0.00128	0.00252	CcSEcCtD
Tranylcypromine—Alopecia—Docetaxel—ovarian cancer	0.00127	0.00252	CcSEcCtD
Tranylcypromine—MAOB—female reproductive system—ovarian cancer	0.00127	0.0346	CbGeAlD
Tranylcypromine—Anxiety—Paclitaxel—ovarian cancer	0.00126	0.00248	CcSEcCtD
Tranylcypromine—Nausea—Topotecan—ovarian cancer	0.00125	0.00246	CcSEcCtD
Tranylcypromine—Dry mouth—Paclitaxel—ovarian cancer	0.00123	0.00243	CcSEcCtD
Tranylcypromine—Diarrhoea—Vinorelbine—ovarian cancer	0.00123	0.00243	CcSEcCtD
Tranylcypromine—Ataxia—Doxorubicin—ovarian cancer	0.00122	0.00241	CcSEcCtD
Tranylcypromine—Nausea—Melphalan—ovarian cancer	0.00122	0.00241	CcSEcCtD
Tranylcypromine—Confusional state—Paclitaxel—ovarian cancer	0.00122	0.00241	CcSEcCtD
Tranylcypromine—Oedema—Paclitaxel—ovarian cancer	0.00121	0.00239	CcSEcCtD
Tranylcypromine—Muscle spasms—Docetaxel—ovarian cancer	0.00121	0.00238	CcSEcCtD
Tranylcypromine—MAOA—uterus—ovarian cancer	0.0012	0.0328	CbGeAlD
Tranylcypromine—Shock—Paclitaxel—ovarian cancer	0.00119	0.00235	CcSEcCtD
Tranylcypromine—Dizziness—Vinorelbine—ovarian cancer	0.00119	0.00235	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00118	0.00234	CcSEcCtD
Tranylcypromine—Tachycardia—Paclitaxel—ovarian cancer	0.00118	0.00233	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00117	0.00231	CcSEcCtD
Tranylcypromine—Anaemia—Docetaxel—ovarian cancer	0.00116	0.00229	CcSEcCtD
Tranylcypromine—MAOB—female gonad—ovarian cancer	0.00115	0.0315	CbGeAlD
Tranylcypromine—Anorexia—Paclitaxel—ovarian cancer	0.00115	0.00227	CcSEcCtD
Tranylcypromine—MAOB—vagina—ovarian cancer	0.00115	0.0313	CbGeAlD
Tranylcypromine—Vomiting—Vinorelbine—ovarian cancer	0.00114	0.00226	CcSEcCtD
Tranylcypromine—Rash—Vinorelbine—ovarian cancer	0.00113	0.00224	CcSEcCtD
Tranylcypromine—Dermatitis—Vinorelbine—ovarian cancer	0.00113	0.00223	CcSEcCtD
Tranylcypromine—Hypotension—Paclitaxel—ovarian cancer	0.00113	0.00223	CcSEcCtD
Tranylcypromine—Headache—Vinorelbine—ovarian cancer	0.00112	0.00222	CcSEcCtD
Tranylcypromine—Syncope—Docetaxel—ovarian cancer	0.00112	0.00222	CcSEcCtD
Tranylcypromine—Leukopenia—Docetaxel—ovarian cancer	0.00112	0.00222	CcSEcCtD
Tranylcypromine—Pollakiuria—Epirubicin—ovarian cancer	0.00112	0.00222	CcSEcCtD
Tranylcypromine—Palpitations—Docetaxel—ovarian cancer	0.00111	0.00219	CcSEcCtD
Tranylcypromine—Loss of consciousness—Docetaxel—ovarian cancer	0.0011	0.00218	CcSEcCtD
Tranylcypromine—Insomnia—Paclitaxel—ovarian cancer	0.00109	0.00216	CcSEcCtD
Tranylcypromine—Paraesthesia—Paclitaxel—ovarian cancer	0.00108	0.00214	CcSEcCtD
Tranylcypromine—Hypertension—Docetaxel—ovarian cancer	0.00108	0.00214	CcSEcCtD
Tranylcypromine—Drowsiness—Epirubicin—ovarian cancer	0.00108	0.00214	CcSEcCtD
Tranylcypromine—MAOA—female reproductive system—ovarian cancer	0.00108	0.0295	CbGeAlD
Tranylcypromine—Somnolence—Paclitaxel—ovarian cancer	0.00107	0.00212	CcSEcCtD
Tranylcypromine—Nausea—Vinorelbine—ovarian cancer	0.00107	0.00211	CcSEcCtD
Tranylcypromine—Decreased appetite—Paclitaxel—ovarian cancer	0.00105	0.00207	CcSEcCtD
Tranylcypromine—Dry mouth—Docetaxel—ovarian cancer	0.00104	0.00206	CcSEcCtD
Tranylcypromine—Sweating—Epirubicin—ovarian cancer	0.00104	0.00205	CcSEcCtD
Tranylcypromine—Pollakiuria—Doxorubicin—ovarian cancer	0.00104	0.00205	CcSEcCtD
Tranylcypromine—Pain—Paclitaxel—ovarian cancer	0.00103	0.00204	CcSEcCtD
Tranylcypromine—Constipation—Paclitaxel—ovarian cancer	0.00103	0.00204	CcSEcCtD
Tranylcypromine—Confusional state—Docetaxel—ovarian cancer	0.00103	0.00204	CcSEcCtD
Tranylcypromine—Oedema—Docetaxel—ovarian cancer	0.00102	0.00202	CcSEcCtD
Tranylcypromine—MAOB—testis—ovarian cancer	0.00102	0.0279	CbGeAlD
Tranylcypromine—Agranulocytosis—Epirubicin—ovarian cancer	0.00101	0.002	CcSEcCtD
Tranylcypromine—Shock—Docetaxel—ovarian cancer	0.00101	0.00199	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Docetaxel—ovarian cancer	0.001	0.00198	CcSEcCtD
Tranylcypromine—Drowsiness—Doxorubicin—ovarian cancer	0.001	0.00198	CcSEcCtD
Tranylcypromine—Tachycardia—Docetaxel—ovarian cancer	0.000999	0.00197	CcSEcCtD
Tranylcypromine—CYP2C19—vagina—ovarian cancer	0.000999	0.0273	CbGeAlD
Tranylcypromine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000995	0.00197	CcSEcCtD
Tranylcypromine—Bradycardia—Epirubicin—ovarian cancer	0.000989	0.00195	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000987	0.00195	CcSEcCtD
Tranylcypromine—MAOA—female gonad—ovarian cancer	0.000984	0.0269	CbGeAlD
Tranylcypromine—MAOA—vagina—ovarian cancer	0.000978	0.0267	CbGeAlD
Tranylcypromine—Haemoglobin—Epirubicin—ovarian cancer	0.000977	0.00193	CcSEcCtD
Tranylcypromine—Anorexia—Docetaxel—ovarian cancer	0.000975	0.00193	CcSEcCtD
Tranylcypromine—Hepatitis—Epirubicin—ovarian cancer	0.000972	0.00192	CcSEcCtD
Tranylcypromine—Haemorrhage—Epirubicin—ovarian cancer	0.000972	0.00192	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Epirubicin—ovarian cancer	0.000967	0.00191	CcSEcCtD
Tranylcypromine—Sweating—Doxorubicin—ovarian cancer	0.00096	0.0019	CcSEcCtD
Tranylcypromine—Urticaria—Paclitaxel—ovarian cancer	0.000959	0.0019	CcSEcCtD
Tranylcypromine—Hypotension—Docetaxel—ovarian cancer	0.000956	0.00189	CcSEcCtD
Tranylcypromine—Abdominal pain—Paclitaxel—ovarian cancer	0.000954	0.00189	CcSEcCtD
Tranylcypromine—Body temperature increased—Paclitaxel—ovarian cancer	0.000954	0.00189	CcSEcCtD
Tranylcypromine—Agranulocytosis—Doxorubicin—ovarian cancer	0.000935	0.00185	CcSEcCtD
Tranylcypromine—Insomnia—Docetaxel—ovarian cancer	0.000926	0.00183	CcSEcCtD
Tranylcypromine—Paraesthesia—Docetaxel—ovarian cancer	0.000919	0.00182	CcSEcCtD
Tranylcypromine—Bradycardia—Doxorubicin—ovarian cancer	0.000915	0.00181	CcSEcCtD
Tranylcypromine—Somnolence—Docetaxel—ovarian cancer	0.00091	0.0018	CcSEcCtD
Tranylcypromine—Tinnitus—Epirubicin—ovarian cancer	0.000906	0.00179	CcSEcCtD
Tranylcypromine—Haemoglobin—Doxorubicin—ovarian cancer	0.000904	0.00179	CcSEcCtD
Tranylcypromine—Flushing—Epirubicin—ovarian cancer	0.000902	0.00178	CcSEcCtD
Tranylcypromine—Haemorrhage—Doxorubicin—ovarian cancer	0.000899	0.00178	CcSEcCtD
Tranylcypromine—Hepatitis—Doxorubicin—ovarian cancer	0.000899	0.00178	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000894	0.00177	CcSEcCtD
Tranylcypromine—Decreased appetite—Docetaxel—ovarian cancer	0.00089	0.00176	CcSEcCtD
Tranylcypromine—Constipation—Docetaxel—ovarian cancer	0.000875	0.00173	CcSEcCtD
Tranylcypromine—Pain—Docetaxel—ovarian cancer	0.000875	0.00173	CcSEcCtD
Tranylcypromine—MAOA—testis—ovarian cancer	0.000872	0.0238	CbGeAlD
Tranylcypromine—Chills—Epirubicin—ovarian cancer	0.000872	0.00172	CcSEcCtD
Tranylcypromine—Asthenia—Paclitaxel—ovarian cancer	0.000866	0.00171	CcSEcCtD
Tranylcypromine—Alopecia—Epirubicin—ovarian cancer	0.000859	0.0017	CcSEcCtD
Tranylcypromine—CYP2C9—female reproductive system—ovarian cancer	0.000856	0.0234	CbGeAlD
Tranylcypromine—Feeling abnormal—Docetaxel—ovarian cancer	0.000843	0.00167	CcSEcCtD
Tranylcypromine—Tinnitus—Doxorubicin—ovarian cancer	0.000838	0.00166	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000837	0.00165	CcSEcCtD
Tranylcypromine—Flushing—Doxorubicin—ovarian cancer	0.000834	0.00165	CcSEcCtD
Tranylcypromine—Diarrhoea—Paclitaxel—ovarian cancer	0.000826	0.00163	CcSEcCtD
Tranylcypromine—Muscle spasms—Epirubicin—ovarian cancer	0.000813	0.00161	CcSEcCtD
Tranylcypromine—CYP2E1—female reproductive system—ovarian cancer	0.000811	0.0222	CbGeAlD
Tranylcypromine—Body temperature increased—Docetaxel—ovarian cancer	0.000809	0.0016	CcSEcCtD
Tranylcypromine—Abdominal pain—Docetaxel—ovarian cancer	0.000809	0.0016	CcSEcCtD
Tranylcypromine—Chills—Doxorubicin—ovarian cancer	0.000807	0.00159	CcSEcCtD
Tranylcypromine—Dizziness—Paclitaxel—ovarian cancer	0.000798	0.00158	CcSEcCtD
Tranylcypromine—Vision blurred—Epirubicin—ovarian cancer	0.000797	0.00158	CcSEcCtD
Tranylcypromine—Alopecia—Doxorubicin—ovarian cancer	0.000794	0.00157	CcSEcCtD
Tranylcypromine—Anaemia—Epirubicin—ovarian cancer	0.000782	0.00154	CcSEcCtD
Tranylcypromine—Agitation—Epirubicin—ovarian cancer	0.000777	0.00154	CcSEcCtD
Tranylcypromine—Vomiting—Paclitaxel—ovarian cancer	0.000768	0.00152	CcSEcCtD
Tranylcypromine—Rash—Paclitaxel—ovarian cancer	0.000761	0.0015	CcSEcCtD
Tranylcypromine—Dermatitis—Paclitaxel—ovarian cancer	0.000761	0.0015	CcSEcCtD
Tranylcypromine—Syncope—Epirubicin—ovarian cancer	0.000758	0.0015	CcSEcCtD
Tranylcypromine—Leukopenia—Epirubicin—ovarian cancer	0.000757	0.0015	CcSEcCtD
Tranylcypromine—Headache—Paclitaxel—ovarian cancer	0.000756	0.00149	CcSEcCtD
Tranylcypromine—Muscle spasms—Doxorubicin—ovarian cancer	0.000752	0.00149	CcSEcCtD
Tranylcypromine—Palpitations—Epirubicin—ovarian cancer	0.000747	0.00148	CcSEcCtD
Tranylcypromine—Loss of consciousness—Epirubicin—ovarian cancer	0.000743	0.00147	CcSEcCtD
Tranylcypromine—MAOB—lymph node—ovarian cancer	0.000741	0.0202	CbGeAlD
Tranylcypromine—Vision blurred—Doxorubicin—ovarian cancer	0.000738	0.00146	CcSEcCtD
Tranylcypromine—Asthenia—Docetaxel—ovarian cancer	0.000734	0.00145	CcSEcCtD
Tranylcypromine—Hypertension—Epirubicin—ovarian cancer	0.00073	0.00144	CcSEcCtD
Tranylcypromine—Anaemia—Doxorubicin—ovarian cancer	0.000723	0.00143	CcSEcCtD
Tranylcypromine—Agitation—Doxorubicin—ovarian cancer	0.000719	0.00142	CcSEcCtD
Tranylcypromine—Anxiety—Epirubicin—ovarian cancer	0.000718	0.00142	CcSEcCtD
Tranylcypromine—Nausea—Paclitaxel—ovarian cancer	0.000717	0.00142	CcSEcCtD
Tranylcypromine—Dry mouth—Epirubicin—ovarian cancer	0.000704	0.00139	CcSEcCtD
Tranylcypromine—Syncope—Doxorubicin—ovarian cancer	0.000702	0.00139	CcSEcCtD
Tranylcypromine—Leukopenia—Doxorubicin—ovarian cancer	0.0007	0.00138	CcSEcCtD
Tranylcypromine—Diarrhoea—Docetaxel—ovarian cancer	0.0007	0.00138	CcSEcCtD
Tranylcypromine—Confusional state—Epirubicin—ovarian cancer	0.000696	0.00138	CcSEcCtD
Tranylcypromine—Palpitations—Doxorubicin—ovarian cancer	0.000692	0.00137	CcSEcCtD
Tranylcypromine—Oedema—Epirubicin—ovarian cancer	0.00069	0.00136	CcSEcCtD
Tranylcypromine—Loss of consciousness—Doxorubicin—ovarian cancer	0.000688	0.00136	CcSEcCtD
Tranylcypromine—Shock—Epirubicin—ovarian cancer	0.000679	0.00134	CcSEcCtD
Tranylcypromine—Dizziness—Docetaxel—ovarian cancer	0.000677	0.00134	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Epirubicin—ovarian cancer	0.000676	0.00134	CcSEcCtD
Tranylcypromine—Hypertension—Doxorubicin—ovarian cancer	0.000676	0.00134	CcSEcCtD
Tranylcypromine—Tachycardia—Epirubicin—ovarian cancer	0.000674	0.00133	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Epirubicin—ovarian cancer	0.000667	0.00132	CcSEcCtD
Tranylcypromine—Anxiety—Doxorubicin—ovarian cancer	0.000664	0.00131	CcSEcCtD
Tranylcypromine—Anorexia—Epirubicin—ovarian cancer	0.000658	0.0013	CcSEcCtD
Tranylcypromine—CYP2E1—testis—ovarian cancer	0.000655	0.0179	CbGeAlD
Tranylcypromine—CYP3A4—female reproductive system—ovarian cancer	0.000653	0.0178	CbGeAlD
Tranylcypromine—Dry mouth—Doxorubicin—ovarian cancer	0.000652	0.00129	CcSEcCtD
Tranylcypromine—Vomiting—Docetaxel—ovarian cancer	0.000651	0.00129	CcSEcCtD
Tranylcypromine—Rash—Docetaxel—ovarian cancer	0.000645	0.00128	CcSEcCtD
Tranylcypromine—Hypotension—Epirubicin—ovarian cancer	0.000645	0.00127	CcSEcCtD
Tranylcypromine—Dermatitis—Docetaxel—ovarian cancer	0.000645	0.00127	CcSEcCtD
Tranylcypromine—Confusional state—Doxorubicin—ovarian cancer	0.000644	0.00127	CcSEcCtD
Tranylcypromine—CYP2D6—female reproductive system—ovarian cancer	0.000642	0.0175	CbGeAlD
Tranylcypromine—Headache—Docetaxel—ovarian cancer	0.000641	0.00127	CcSEcCtD
Tranylcypromine—Oedema—Doxorubicin—ovarian cancer	0.000639	0.00126	CcSEcCtD
Tranylcypromine—MAOA—lymph node—ovarian cancer	0.000632	0.0173	CbGeAlD
Tranylcypromine—Shock—Doxorubicin—ovarian cancer	0.000628	0.00124	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000625	0.00124	CcSEcCtD
Tranylcypromine—Insomnia—Epirubicin—ovarian cancer	0.000624	0.00123	CcSEcCtD
Tranylcypromine—Tachycardia—Doxorubicin—ovarian cancer	0.000623	0.00123	CcSEcCtD
Tranylcypromine—Paraesthesia—Epirubicin—ovarian cancer	0.00062	0.00122	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000617	0.00122	CcSEcCtD
Tranylcypromine—Somnolence—Epirubicin—ovarian cancer	0.000614	0.00121	CcSEcCtD
Tranylcypromine—Anorexia—Doxorubicin—ovarian cancer	0.000609	0.0012	CcSEcCtD
Tranylcypromine—Nausea—Docetaxel—ovarian cancer	0.000608	0.0012	CcSEcCtD
Tranylcypromine—Decreased appetite—Epirubicin—ovarian cancer	0.0006	0.00119	CcSEcCtD
Tranylcypromine—Hypotension—Doxorubicin—ovarian cancer	0.000597	0.00118	CcSEcCtD
Tranylcypromine—Constipation—Epirubicin—ovarian cancer	0.00059	0.00117	CcSEcCtD
Tranylcypromine—Pain—Epirubicin—ovarian cancer	0.00059	0.00117	CcSEcCtD
Tranylcypromine—CYP2D6—female gonad—ovarian cancer	0.000585	0.016	CbGeAlD
Tranylcypromine—Insomnia—Doxorubicin—ovarian cancer	0.000578	0.00114	CcSEcCtD
Tranylcypromine—Paraesthesia—Doxorubicin—ovarian cancer	0.000574	0.00113	CcSEcCtD
Tranylcypromine—Feeling abnormal—Epirubicin—ovarian cancer	0.000569	0.00112	CcSEcCtD
Tranylcypromine—Somnolence—Doxorubicin—ovarian cancer	0.000568	0.00112	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000564	0.00112	CcSEcCtD
Tranylcypromine—Decreased appetite—Doxorubicin—ovarian cancer	0.000555	0.0011	CcSEcCtD
Tranylcypromine—Urticaria—Epirubicin—ovarian cancer	0.000548	0.00108	CcSEcCtD
Tranylcypromine—Pain—Doxorubicin—ovarian cancer	0.000546	0.00108	CcSEcCtD
Tranylcypromine—Constipation—Doxorubicin—ovarian cancer	0.000546	0.00108	CcSEcCtD
Tranylcypromine—Abdominal pain—Epirubicin—ovarian cancer	0.000546	0.00108	CcSEcCtD
Tranylcypromine—Body temperature increased—Epirubicin—ovarian cancer	0.000546	0.00108	CcSEcCtD
Tranylcypromine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000526	0.00104	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000522	0.00103	CcSEcCtD
Tranylcypromine—CYP2D6—testis—ovarian cancer	0.000518	0.0142	CbGeAlD
Tranylcypromine—Urticaria—Doxorubicin—ovarian cancer	0.000507	0.001	CcSEcCtD
Tranylcypromine—Abdominal pain—Doxorubicin—ovarian cancer	0.000505	0.000998	CcSEcCtD
Tranylcypromine—Body temperature increased—Doxorubicin—ovarian cancer	0.000505	0.000998	CcSEcCtD
Tranylcypromine—Asthenia—Epirubicin—ovarian cancer	0.000495	0.000979	CcSEcCtD
Tranylcypromine—Diarrhoea—Epirubicin—ovarian cancer	0.000472	0.000933	CcSEcCtD
Tranylcypromine—Asthenia—Doxorubicin—ovarian cancer	0.000458	0.000906	CcSEcCtD
Tranylcypromine—Dizziness—Epirubicin—ovarian cancer	0.000456	0.000902	CcSEcCtD
Tranylcypromine—Vomiting—Epirubicin—ovarian cancer	0.000439	0.000867	CcSEcCtD
Tranylcypromine—Diarrhoea—Doxorubicin—ovarian cancer	0.000437	0.000864	CcSEcCtD
Tranylcypromine—Rash—Epirubicin—ovarian cancer	0.000435	0.00086	CcSEcCtD
Tranylcypromine—Dermatitis—Epirubicin—ovarian cancer	0.000435	0.000859	CcSEcCtD
Tranylcypromine—Headache—Epirubicin—ovarian cancer	0.000432	0.000855	CcSEcCtD
Tranylcypromine—Dizziness—Doxorubicin—ovarian cancer	0.000422	0.000835	CcSEcCtD
Tranylcypromine—Nausea—Epirubicin—ovarian cancer	0.00041	0.00081	CcSEcCtD
Tranylcypromine—Vomiting—Doxorubicin—ovarian cancer	0.000406	0.000802	CcSEcCtD
Tranylcypromine—Rash—Doxorubicin—ovarian cancer	0.000403	0.000796	CcSEcCtD
Tranylcypromine—Dermatitis—Doxorubicin—ovarian cancer	0.000402	0.000795	CcSEcCtD
Tranylcypromine—Headache—Doxorubicin—ovarian cancer	0.0004	0.000791	CcSEcCtD
Tranylcypromine—Nausea—Doxorubicin—ovarian cancer	0.000379	0.00075	CcSEcCtD
Tranylcypromine—CYP2A6—NRF2 pathway—SLC5A5—ovarian cancer	0.000262	0.00369	CbGpPWpGaD
Tranylcypromine—CYP2A6—NRF2 pathway—SLC2A1—ovarian cancer	0.000253	0.00357	CbGpPWpGaD
Tranylcypromine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.000247	0.00348	CbGpPWpGaD
Tranylcypromine—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000244	0.00344	CbGpPWpGaD
Tranylcypromine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.000235	0.00331	CbGpPWpGaD
Tranylcypromine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000235	0.00331	CbGpPWpGaD
Tranylcypromine—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000232	0.00326	CbGpPWpGaD
Tranylcypromine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000225	0.00317	CbGpPWpGaD
Tranylcypromine—CYP3A4—Tryptophan metabolism—CYP1B1—ovarian cancer	0.000224	0.00316	CbGpPWpGaD
Tranylcypromine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000223	0.00314	CbGpPWpGaD
Tranylcypromine—CYP2A6—Fluoropyrimidine Activity—TP53—ovarian cancer	0.000214	0.00301	CbGpPWpGaD
Tranylcypromine—CYP2A6—Biological oxidations—CYP1B1—ovarian cancer	0.000213	0.003	CbGpPWpGaD
Tranylcypromine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.00019	0.00268	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—ovarian cancer	0.000182	0.00257	CbGpPWpGaD
Tranylcypromine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000181	0.00255	CbGpPWpGaD
Tranylcypromine—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000179	0.00252	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—CYTB—ovarian cancer	0.000172	0.00242	CbGpPWpGaD
Tranylcypromine—CYP2E1—Biological oxidations—CYP1B1—ovarian cancer	0.000168	0.00237	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—NME2—ovarian cancer	0.000167	0.00235	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000166	0.00234	CbGpPWpGaD
Tranylcypromine—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—ovarian cancer	0.000163	0.0023	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—BRIP1—ovarian cancer	0.00015	0.00211	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—PPP1CC—ovarian cancer	0.00015	0.00211	CbGpPWpGaD
Tranylcypromine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000147	0.00207	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—NME2—ovarian cancer	0.00013	0.00183	CbGpPWpGaD
Tranylcypromine—CYP2C19—Biological oxidations—CYP1B1—ovarian cancer	0.00013	0.00183	CbGpPWpGaD
Tranylcypromine—MAOA—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	0.000129	0.00183	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000128	0.0018	CbGpPWpGaD
Tranylcypromine—MAOA—SIDS Susceptibility Pathways—CASP3—ovarian cancer	0.000124	0.00175	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ovarian cancer	0.000124	0.00175	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ovarian cancer	0.000124	0.00175	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ovarian cancer	0.000121	0.00171	CbGpPWpGaD
Tranylcypromine—MAOA—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	0.000119	0.00168	CbGpPWpGaD
Tranylcypromine—CYP2D6—Biological oxidations—CYP1B1—ovarian cancer	0.000119	0.00168	CbGpPWpGaD
Tranylcypromine—CYP2C9—Biological oxidations—CYP1B1—ovarian cancer	0.000118	0.00167	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000118	0.00166	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000117	0.00164	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—CYTB—ovarian cancer	0.000108	0.00152	CbGpPWpGaD
Tranylcypromine—MAOA—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	0.000105	0.00148	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—ovarian cancer	0.000103	0.00145	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—NME2—ovarian cancer	0.000102	0.00144	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—ovarian cancer	0.000102	0.00143	CbGpPWpGaD
Tranylcypromine—CYP1A2—Biological oxidations—CYP1B1—ovarian cancer	0.000101	0.00142	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—YAP1—ovarian cancer	0.000101	0.00142	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.0001	0.00141	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metapathway biotransformation—CYP1B1—ovarian cancer	9.97e-05	0.0014	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	9.48e-05	0.00134	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PPP1CC—ovarian cancer	9.41e-05	0.00133	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—BRIP1—ovarian cancer	9.41e-05	0.00133	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	9.28e-05	0.00131	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	9.27e-05	0.00131	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	9.27e-05	0.00131	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	9.12e-05	0.00129	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	8.76e-05	0.00123	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—CYTB—ovarian cancer	8.36e-05	0.00118	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—FASN—ovarian cancer	8.2e-05	0.00116	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—SLC5A5—ovarian cancer	8.07e-05	0.00114	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—NME2—ovarian cancer	7.91e-05	0.00111	CbGpPWpGaD
Tranylcypromine—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	7.8e-05	0.0011	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	7.79e-05	0.0011	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—SLC2A1—ovarian cancer	7.79e-05	0.0011	CbGpPWpGaD
Tranylcypromine—MAOA—Transmission across Chemical Synapses—MAPK1—ovarian cancer	7.76e-05	0.00109	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	7.69e-05	0.00108	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—CYP1B1—ovarian cancer	7.47e-05	0.00105	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	7.45e-05	0.00105	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PPP1CC—ovarian cancer	7.31e-05	0.00103	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—BRIP1—ovarian cancer	7.31e-05	0.00103	CbGpPWpGaD
Tranylcypromine—MAOA—SIDS Susceptibility Pathways—IL6—ovarian cancer	7.27e-05	0.00103	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—NME2—ovarian cancer	7.27e-05	0.00103	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—NME2—ovarian cancer	7.21e-05	0.00102	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	6.71e-05	0.000946	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—PPP2R1A—ovarian cancer	6.62e-05	0.000934	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—CYTB—ovarian cancer	6.6e-05	0.000931	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—YAP1—ovarian cancer	6.31e-05	0.00089	CbGpPWpGaD
Tranylcypromine—MAOA—Transmission across Chemical Synapses—HRAS—ovarian cancer	6.23e-05	0.000878	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—NME2—ovarian cancer	6.16e-05	0.000869	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—ABCB1—ovarian cancer	6.15e-05	0.000867	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	6.12e-05	0.000862	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—TYMS—ovarian cancer	6.04e-05	0.000851	CbGpPWpGaD
Tranylcypromine—MAOA—Neuronal System—MAPK1—ovarian cancer	5.95e-05	0.000838	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—BRIP1—ovarian cancer	5.77e-05	0.000814	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PPP1CC—ovarian cancer	5.77e-05	0.000814	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	5.47e-05	0.000771	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	5.23e-05	0.000737	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—FASN—ovarian cancer	5.14e-05	0.000725	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CYTB—ovarian cancer	5.1e-05	0.000718	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—SLC5A5—ovarian cancer	5.06e-05	0.000713	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	4.99e-05	0.000703	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	4.98e-05	0.000702	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—YAP1—ovarian cancer	4.9e-05	0.000691	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—SLC2A1—ovarian cancer	4.89e-05	0.000689	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—CAV1—ovarian cancer	4.87e-05	0.000686	CbGpPWpGaD
Tranylcypromine—MAOA—Neuronal System—HRAS—ovarian cancer	4.77e-05	0.000673	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—NME2—ovarian cancer	4.76e-05	0.00067	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CYTB—ovarian cancer	4.69e-05	0.000661	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—CYP1B1—ovarian cancer	4.69e-05	0.000661	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CYTB—ovarian cancer	4.65e-05	0.000655	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	4.54e-05	0.00064	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—BRIP1—ovarian cancer	4.45e-05	0.000628	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PPP1CC—ovarian cancer	4.45e-05	0.000628	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—PIK3CG—ovarian cancer	4.43e-05	0.000625	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	4.26e-05	0.000601	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PPP2R1A—ovarian cancer	4.16e-05	0.000586	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—BRIP1—ovarian cancer	4.1e-05	0.000577	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PPP1CC—ovarian cancer	4.1e-05	0.000577	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PPP1CC—ovarian cancer	4.06e-05	0.000572	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—BRIP1—ovarian cancer	4.06e-05	0.000572	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—FASN—ovarian cancer	3.99e-05	0.000563	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CYTB—ovarian cancer	3.97e-05	0.00056	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—SLC5A5—ovarian cancer	3.93e-05	0.000554	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—PIK3CD—ovarian cancer	3.9e-05	0.000549	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	3.88e-05	0.000547	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—YAP1—ovarian cancer	3.87e-05	0.000546	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—ABCB1—ovarian cancer	3.86e-05	0.000544	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—SLC2A1—ovarian cancer	3.79e-05	0.000535	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—TYMS—ovarian cancer	3.79e-05	0.000534	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—CYP1B1—ovarian cancer	3.64e-05	0.000513	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PPP1CC—ovarian cancer	3.47e-05	0.000489	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—BRIP1—ovarian cancer	3.47e-05	0.000489	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—PIK3CB—ovarian cancer	3.4e-05	0.000479	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.25e-05	0.000458	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PPP2R1A—ovarian cancer	3.23e-05	0.000455	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—FASN—ovarian cancer	3.16e-05	0.000445	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—SLC5A5—ovarian cancer	3.1e-05	0.000438	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CYTB—ovarian cancer	3.06e-05	0.000432	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—CAV1—ovarian cancer	3.05e-05	0.00043	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—SLC2A1—ovarian cancer	3e-05	0.000423	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—ABCB1—ovarian cancer	3e-05	0.000422	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—YAP1—ovarian cancer	2.99e-05	0.000421	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.96e-05	0.000417	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.96e-05	0.000417	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—TYMS—ovarian cancer	2.94e-05	0.000415	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—PTEN—ovarian cancer	2.94e-05	0.000414	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—CYP1B1—ovarian cancer	2.87e-05	0.000405	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PIK3CG—ovarian cancer	2.78e-05	0.000392	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—YAP1—ovarian cancer	2.75e-05	0.000387	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—YAP1—ovarian cancer	2.72e-05	0.000384	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.7e-05	0.00038	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—BRIP1—ovarian cancer	2.68e-05	0.000378	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PPP1CC—ovarian cancer	2.68e-05	0.000378	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.6e-05	0.000366	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	2.55e-05	0.000359	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.53e-05	0.000356	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PIK3CD—ovarian cancer	2.45e-05	0.000345	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—FASN—ovarian cancer	2.44e-05	0.000343	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—SLC5A5—ovarian cancer	2.4e-05	0.000338	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—CAV1—ovarian cancer	2.37e-05	0.000334	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.37e-05	0.000334	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—ABCB1—ovarian cancer	2.37e-05	0.000334	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—YAP1—ovarian cancer	2.33e-05	0.000328	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—TYMS—ovarian cancer	2.33e-05	0.000328	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—SLC2A1—ovarian cancer	2.31e-05	0.000326	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.3e-05	0.000325	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.27e-05	0.000319	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—FASN—ovarian cancer	2.24e-05	0.000316	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—FASN—ovarian cancer	2.22e-05	0.000313	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CYP1B1—ovarian cancer	2.22e-05	0.000313	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—SLC5A5—ovarian cancer	2.2e-05	0.000311	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—SLC5A5—ovarian cancer	2.18e-05	0.000308	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PIK3CG—ovarian cancer	2.16e-05	0.000304	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PIK3CB—ovarian cancer	2.13e-05	0.0003	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—SLC2A1—ovarian cancer	2.13e-05	0.0003	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—SLC2A1—ovarian cancer	2.11e-05	0.000297	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—PIK3CA—ovarian cancer	2.07e-05	0.000292	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.07e-05	0.000291	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CYP1B1—ovarian cancer	2.04e-05	0.000288	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.03e-05	0.000285	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CYP1B1—ovarian cancer	2.02e-05	0.000285	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	1.97e-05	0.000277	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.96e-05	0.000276	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PIK3CD—ovarian cancer	1.9e-05	0.000268	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—FASN—ovarian cancer	1.9e-05	0.000267	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—CAV1—ovarian cancer	1.87e-05	0.000264	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—SLC5A5—ovarian cancer	1.87e-05	0.000263	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PTEN—ovarian cancer	1.84e-05	0.00026	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—ABCB1—ovarian cancer	1.83e-05	0.000257	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	1.81e-05	0.000255	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—SLC2A1—ovarian cancer	1.8e-05	0.000254	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—YAP1—ovarian cancer	1.8e-05	0.000253	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—TYMS—ovarian cancer	1.79e-05	0.000253	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	1.79e-05	0.000253	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.78e-05	0.000252	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.77e-05	0.000249	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CYP1B1—ovarian cancer	1.73e-05	0.000244	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PIK3CG—ovarian cancer	1.71e-05	0.000241	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—AKT1—ovarian cancer	1.69e-05	0.000238	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—ABCB1—ovarian cancer	1.68e-05	0.000237	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—ABCB1—ovarian cancer	1.67e-05	0.000235	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PIK3CB—ovarian cancer	1.65e-05	0.000233	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—TYMS—ovarian cancer	1.65e-05	0.000233	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—TYMS—ovarian cancer	1.64e-05	0.000231	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	1.53e-05	0.000216	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.53e-05	0.000215	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PIK3CD—ovarian cancer	1.5e-05	0.000211	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—FASN—ovarian cancer	1.46e-05	0.000206	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CAV1—ovarian cancer	1.45e-05	0.000204	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—SLC5A5—ovarian cancer	1.44e-05	0.000203	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PTEN—ovarian cancer	1.43e-05	0.000202	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ABCB1—ovarian cancer	1.42e-05	0.000201	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—TYMS—ovarian cancer	1.4e-05	0.000197	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—SLC2A1—ovarian cancer	1.39e-05	0.000196	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.38e-05	0.000195	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CYP1B1—ovarian cancer	1.33e-05	0.000188	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CAV1—ovarian cancer	1.33e-05	0.000187	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CAV1—ovarian cancer	1.32e-05	0.000186	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PIK3CG—ovarian cancer	1.32e-05	0.000186	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PIK3CB—ovarian cancer	1.31e-05	0.000184	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PIK3CA—ovarian cancer	1.3e-05	0.000183	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.26e-05	0.000177	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PIK3CG—ovarian cancer	1.21e-05	0.000171	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PIK3CG—ovarian cancer	1.2e-05	0.000169	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	1.18e-05	0.000167	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PIK3CD—ovarian cancer	1.16e-05	0.000163	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PTEN—ovarian cancer	1.13e-05	0.000159	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CAV1—ovarian cancer	1.13e-05	0.000159	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ABCB1—ovarian cancer	1.1e-05	0.000155	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—TYMS—ovarian cancer	1.08e-05	0.000152	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.08e-05	0.000152	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PIK3CD—ovarian cancer	1.06e-05	0.00015	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—AKT1—ovarian cancer	1.06e-05	0.00015	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PIK3CD—ovarian cancer	1.06e-05	0.000149	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PIK3CG—ovarian cancer	1.03e-05	0.000145	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PIK3CB—ovarian cancer	1.01e-05	0.000142	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PIK3CA—ovarian cancer	1.01e-05	0.000142	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PIK3CB—ovarian cancer	9.28e-06	0.000131	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PIK3CB—ovarian cancer	9.2e-06	0.00013	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PIK3CD—ovarian cancer	9.02e-06	0.000127	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PTEN—ovarian cancer	8.72e-06	0.000123	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CAV1—ovarian cancer	8.69e-06	0.000123	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—AKT1—ovarian cancer	8.24e-06	0.000116	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PTEN—ovarian cancer	8.02e-06	0.000113	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PIK3CA—ovarian cancer	7.97e-06	0.000112	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PTEN—ovarian cancer	7.95e-06	0.000112	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PIK3CG—ovarian cancer	7.92e-06	0.000112	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PIK3CB—ovarian cancer	7.86e-06	0.000111	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PIK3CD—ovarian cancer	6.96e-06	9.81e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PTEN—ovarian cancer	6.79e-06	9.58e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—AKT1—ovarian cancer	6.51e-06	9.18e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PIK3CA—ovarian cancer	6.15e-06	8.67e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PIK3CB—ovarian cancer	6.07e-06	8.55e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PIK3CA—ovarian cancer	5.66e-06	7.97e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PIK3CA—ovarian cancer	5.61e-06	7.9e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PTEN—ovarian cancer	5.24e-06	7.39e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—AKT1—ovarian cancer	5.02e-06	7.08e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PIK3CA—ovarian cancer	4.79e-06	6.75e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—AKT1—ovarian cancer	4.62e-06	6.51e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—AKT1—ovarian cancer	4.58e-06	6.46e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—AKT1—ovarian cancer	3.91e-06	5.52e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PIK3CA—ovarian cancer	3.7e-06	5.21e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—AKT1—ovarian cancer	3.02e-06	4.26e-05	CbGpPWpGaD
